O	0	6	Netrin	Netrin	NN	B-NP
O	6	7	-	-	HYPH	B-NP
O	7	8	1	1	CD	I-NP
O	9	11	up	up	RB	B-ADVP
O	11	12	-	-	HYPH	O
O	12	22	regulation	regulation	NN	B-NP
O	23	25	in	in	IN	B-PP
O	26	38	inflammatory	inflammatory	JJ	B-NP
B-Organ	39	44	bowel	bowel	NN	I-NP
O	45	53	diseases	disease	NNS	I-NP
O	54	56	is	be	VBZ	B-VP
O	57	65	required	require	VBN	I-VP
O	66	69	for	for	IN	B-PP
B-Cancer	70	80	colorectal	colorectal	JJ	B-NP
I-Cancer	81	87	cancer	cancer	NN	I-NP
O	88	99	progression	progression	NN	I-NP
O	99	100	.	.	.	O

O	102	109	Chronic	Chronic	JJ	B-NP
O	110	122	inflammation	inflammation	NN	I-NP
O	123	126	and	and	CC	I-NP
B-Cancer	127	133	cancer	cancer	NN	I-NP
O	134	137	are	be	VBP	B-VP
O	138	148	intimately	intimately	RB	I-VP
O	149	159	associated	associate	VBN	I-VP
O	159	160	.	.	.	O

O	161	165	This	This	DT	B-NP
O	166	168	is	be	VBZ	B-VP
O	169	181	particularly	particularly	RB	B-ADJP
O	182	186	true	true	JJ	I-ADJP
O	187	190	for	for	IN	B-PP
O	191	203	inflammatory	inflammatory	JJ	B-NP
B-Organ	204	209	bowel	bowel	NN	I-NP
O	210	218	diseases	disease	NNS	I-NP
O	219	220	(	(	(	O
O	220	223	IBD	IBD	NN	B-NP
O	223	224	)	)	)	O
O	224	225	,	,	,	O
O	226	230	such	such	JJ	B-PP
O	231	233	as	as	IN	I-PP
B-Pathological_formation	234	244	ulcerative	ulcerative	JJ	B-NP
O	245	252	colitis	colitis	NN	I-NP
O	253	256	and	and	CC	I-NP
O	257	262	Crohn	Crohn	NN	I-NP
O	262	263	'	'	''	I-NP
O	263	264	s	s	NN	I-NP
O	265	272	disease	disease	NN	I-NP
O	272	273	,	,	,	O
O	274	279	which	which	WDT	B-NP
O	280	284	show	show	VBP	B-VP
O	285	286	a	a	DT	B-NP
O	287	292	major	major	JJ	I-NP
O	293	302	increased	increase	VBN	I-NP
O	303	307	risk	risk	NN	I-NP
O	308	311	for	for	IN	B-PP
B-Cancer	312	322	colorectal	colorectal	JJ	B-NP
I-Cancer	323	329	cancer	cancer	NN	I-NP
O	329	330	.	.	.	O

O	331	336	While	While	IN	B-SBAR
O	337	340	the	the	DT	B-NP
O	341	354	understanding	understanding	NN	I-NP
O	355	357	of	of	IN	B-PP
O	358	361	the	the	DT	B-NP
O	362	371	molecular	molecular	JJ	I-NP
O	372	384	pathogenesis	pathogenesis	NN	I-NP
O	385	387	of	of	IN	B-PP
O	388	391	IBD	IBD	NN	B-NP
O	392	395	has	have	VBZ	B-VP
O	396	404	recently	recently	RB	I-VP
O	405	413	improved	improve	VBN	I-VP
O	413	414	,	,	,	O
O	415	418	the	the	DT	B-NP
O	419	429	mechanisms	mechanism	NNS	I-NP
O	430	434	that	that	WDT	B-NP
O	435	439	link	link	VBP	B-VP
O	440	445	these	these	DT	B-NP
O	446	453	chronic	chronic	JJ	I-NP
O	454	466	inflammatory	inflammatory	JJ	I-NP
O	467	473	states	state	NNS	I-NP
O	474	476	to	to	TO	B-PP
B-Cancer	477	487	colorectal	colorectal	JJ	B-NP
I-Cancer	488	494	cancer	cancer	NN	I-NP
O	495	506	development	development	NN	I-NP
O	507	510	are	be	VBP	B-VP
O	511	513	in	in	IN	B-PP
O	514	519	large	large	JJ	B-NP
O	520	524	part	part	NN	I-NP
O	525	532	unknown	unknown	JJ	B-ADJP
O	532	533	.	.	.	O

O	534	537	One	One	CD	B-NP
O	538	540	of	of	IN	B-PP
O	541	546	these	these	DT	B-NP
O	547	557	mechanisms	mechanism	NNS	I-NP
O	558	560	is	be	VBZ	B-VP
O	561	563	NF	NF	NN	B-NP
O	563	564	-	-	HYPH	B-NP
O	564	570	kappaB	kappaB	NN	I-NP
O	571	578	pathway	pathway	NN	I-NP
O	579	589	activation	activation	NN	I-NP
O	590	595	which	which	WDT	B-NP
O	596	598	in	in	IN	B-PP
O	599	603	turn	turn	NN	B-NP
O	604	607	may	may	MD	B-VP
O	608	618	contribute	contribute	VB	I-VP
O	619	621	to	to	TO	B-PP
B-Cancer	622	627	tumor	tumor	NN	B-NP
O	628	637	formation	formation	NN	I-NP
O	638	640	by	by	IN	B-PP
O	641	650	providing	provide	VBG	B-VP
O	651	655	anti	anti	AFX	B-NP
O	655	656	-	-	HYPH	I-NP
O	656	665	apoptotic	apoptotic	JJ	I-NP
O	666	674	survival	survival	NN	I-NP
O	675	682	signals	signal	NNS	I-NP
O	683	685	to	to	TO	B-PP
O	686	689	the	the	DT	B-NP
B-Cell	690	700	epithelial	epithelial	JJ	I-NP
I-Cell	701	706	cells	cell	NNS	I-NP
O	706	707	.	.	.	O

O	708	713	Based	Base	VBN	B-PP
O	714	716	on	on	IN	B-PP
O	717	720	the	the	DT	B-NP
O	721	732	observation	observation	NN	I-NP
O	733	737	that	that	IN	B-SBAR
O	738	744	netrin	netrin	NN	B-NP
O	744	745	-	-	HYPH	B-NP
O	745	746	1	1	CD	I-NP
O	746	747	,	,	,	O
O	748	751	the	the	DT	B-NP
O	752	756	anti	anti	AFX	I-NP
O	756	757	-	-	HYPH	I-NP
O	757	766	apoptotic	apoptotic	JJ	I-NP
O	767	773	ligand	ligand	NN	I-NP
O	774	777	for	for	IN	B-PP
O	778	781	the	the	DT	B-NP
O	782	792	dependence	dependence	NN	I-NP
O	793	802	receptors	receptor	NNS	I-NP
O	803	806	DCC	DCC	NN	I-NP
O	807	810	and	and	CC	I-NP
O	811	816	UNC5H	UNC5H	NN	I-NP
O	817	819	is	be	VBZ	B-VP
O	820	822	up	up	RB	B-ADVP
O	822	823	-	-	HYPH	B-NP
O	823	832	regulated	regulate	VBN	B-VP
O	833	835	in	in	IN	B-PP
B-Organ	836	843	colonic	colonic	JJ	B-NP
I-Organ	844	850	crypts	crypt	NNS	I-NP
O	851	853	in	in	IN	B-PP
O	854	862	response	response	NN	B-NP
O	863	865	to	to	TO	B-PP
O	866	868	NF	NF	NN	B-NP
O	868	869	-	-	HYPH	O
O	869	875	kappaB	kappaB	NN	B-NP
O	875	876	,	,	,	O
O	877	879	we	we	PRP	B-NP
O	880	884	show	show	VBP	B-VP
O	885	889	here	here	RB	B-ADVP
O	890	894	that	that	IN	B-SBAR
B-Cancer	895	905	colorectal	colorectal	JJ	B-NP
I-Cancer	906	913	cancers	cancer	NNS	I-NP
O	914	918	from	from	IN	B-PP
O	919	931	inflammatory	inflammatory	JJ	B-NP
B-Organ	932	937	bowel	bowel	NN	I-NP
O	938	946	diseases	disease	NNS	I-NP
O	947	955	patients	patient	NNS	I-NP
O	956	960	have	have	VBP	B-VP
O	961	969	selected	select	VBN	I-VP
O	970	972	up	up	RP	B-PRT
O	972	973	-	-	HYPH	B-NP
O	973	983	regulation	regulation	NN	I-NP
O	984	986	of	of	IN	B-PP
O	987	993	netrin	netrin	NN	B-NP
O	993	994	-	-	HYPH	B-NP
O	994	995	1	1	CD	I-NP
O	995	996	.	.	.	O

O	997	1005	Moreover	Moreover	RB	B-ADVP
O	1005	1006	,	,	,	O
O	1007	1009	we	we	PRP	B-NP
O	1010	1021	demonstrate	demonstrate	VBP	B-VP
O	1022	1026	that	that	IN	B-SBAR
O	1027	1031	this	this	DT	B-NP
O	1032	1044	inflammation	inflammation	NN	I-NP
O	1044	1045	-	-	HYPH	B-VP
O	1045	1051	driven	drive	VBN	B-NP
O	1052	1058	netrin	netrin	NN	I-NP
O	1058	1059	-	-	HYPH	B-NP
O	1059	1060	1	1	CD	I-NP
O	1061	1063	up	up	RB	B-ADVP
O	1063	1064	-	-	HYPH	O
O	1064	1074	regulation	regulation	NN	B-NP
O	1075	1077	is	be	VBZ	B-VP
O	1078	1084	causal	causal	JJ	B-ADJP
O	1085	1088	for	for	IN	B-PP
B-Cancer	1089	1099	colorectal	colorectal	JJ	B-NP
I-Cancer	1100	1106	cancer	cancer	NN	I-NP
O	1107	1118	development	development	NN	I-NP
O	1119	1121	as	as	IN	B-PP
O	1122	1134	interference	interference	NN	B-NP
O	1135	1139	with	with	IN	B-PP
O	1140	1146	netrin	netrin	NN	B-NP
O	1146	1147	-	-	HYPH	B-NP
O	1147	1148	1	1	CD	I-NP
O	1149	1158	autocrine	autocrine	JJ	I-NP
O	1159	1163	loop	loop	NN	I-NP
O	1164	1166	in	in	IN	B-PP
O	1167	1168	a	a	DT	B-NP
O	1169	1174	mouse	mouse	NN	I-NP
O	1175	1180	model	model	NN	I-NP
O	1181	1184	for	for	IN	B-PP
B-Pathological_formation	1185	1195	ulcerative	ulcerative	JJ	B-NP
O	1196	1203	colitis	colitis	NN	I-NP
O	1203	1204	-	-	HYPH	O
O	1204	1214	associated	associate	VBN	B-VP
B-Cancer	1215	1225	colorectal	colorectal	JJ	B-NP
I-Cancer	1226	1232	cancer	cancer	NN	I-NP
O	1232	1233	,	,	,	O
O	1234	1239	while	while	IN	B-SBAR
O	1240	1247	showing	show	VBG	B-VP
O	1248	1250	no	no	DT	B-NP
O	1251	1257	effect	effect	NN	I-NP
O	1258	1260	on	on	IN	B-PP
O	1261	1273	inflammation	inflammation	NN	B-NP
O	1273	1274	,	,	,	O
O	1275	1283	inhibits	inhibit	VBZ	B-VP
B-Cancer	1284	1294	colorectal	colorectal	JJ	B-NP
I-Cancer	1295	1301	cancer	cancer	NN	I-NP
O	1302	1313	progression	progression	NN	I-NP
O	1313	1314	.	.	.	O

